| Ytd | -78.28% | |
| 1y | -92.84% |
| Open | 1.14 | Prev Close | 1.13 | Low | 1.09 | High | 1.17 | Mkt Cap | 9.26M |
| Vol | 292.83K | Avg Vol | 291.86K | EPS | -2.12 | P/E | -0.52 | Forward P/E | -3.83 |
| Beta | 1.12 | Short Ratio | 3.71 | Inst. Own | 19.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.76 | 200-d Avg | 4.66 | 1yr Est | 3.34 |
VNRX News
The clinical paper entitled "Prognostic value of circulating H3K27Me3-nucleosomes in newly diagn
HENDERSON, Nev., July 7, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"),
HENDERSON, Nev., June 17, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition")
$4.6 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upo
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
Seeks Strategic Partners to Deploy Nu.Q® Platform in Outbreak Zones HENDERSON, Nev., June 3, 2026 /P
Update Highlights 300% Q1 Revenue Growth, Advance Toward $5 Million Veterinary Milestone, and Active
VolitionRx Limited (VNRX) Q1 2026 Earnings Call Transcript
Conference call to discuss financial and operational results scheduled for Friday, May 15 at 8:30 a
Conference call to take place on Friday, May 15 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev.
The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 mil
HENDERSON, Nev., April 29, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"
HENDERSON, Nev., April 23, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"
HENDERSON, Nev., April 20, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"
VolitionRX (NYSEAMERICAN:VNRX) outlined what management described as a "transformational" period dur
VolitionRx Limited (VNRX) Q4 2025 Earnings Call Transcript
Conference call to discuss financial and operational results scheduled for Wednesday, April 1 at 8:3
HENDERSON, Nev., March 31, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"
Peer Reviewed Clinical Study for Nu.Q® Biomarkers Published in Shock Journal HENDERSON, Nev., March
HENDERSON, Nev., March 26, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"
Conference call to take place on Wednesday, April 1 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev.
Blinded validation cohort achieves over 95% sensitivity for stage I & II cancers with 95% specificit
On Thursday, 930 stocks hit new 52-week lows.
Monday saw 825 companies set new 52-week lows.
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earn